大型医疗设备的使用直接影响医院整体诊疗水平与卫生服务水平，也是促进医院现代化技术水平提升的重要途径。因此，如何在新医疗体制改革背景下加强医院大型医疗设备的维修管理变得尤为重要。本研究以现代医院大型医疗设备维修存在的问题为切入点，提出加强大型医疗设备维修档案的管理等一系列现代医院大型医疗设备维修的主要措施。

医疗设备及耗材是医疗体系中重要的物质部分。传统的医疗设备及耗材管理大多依靠人工或者结合计算机的半自动化管理，容易产生设备或耗材管理混乱、调配不足的情况。为改善这种情况，结合目前流行的物联网技术，通过传感器技术结合云端数据库服务进行数据分析，可以实时监控医疗设备及耗材的使用情况，同时实现医疗设备及耗材的合理调配，从而减少浪费和人工成本。

The scope of the report discusses the dynamics and trends related to the global digital pathology market. In addition, it presents the market estimations and forecasts. It includes revenue generated from various digital pathology modalities such as software, scanner, communication system, and storage systems. For the purpose of the study, the digital pathology market is segmented based on product, type, end user, and region. The study estimates revenue generated from the sales of products such as software, scanner, communication system, and storage systems, which are used for whole slide imaging, image analysis informatics, information management system storage & communication, and others. Moreover, it provides information on end users such as educational, clinical, and pharma & biotech companies. However, the report excludes the revenue generated from the digital pathology services. Furthermore, it does not take into consideration the scope of bar coding.

The biggest trend observed in recent years in relation to medical contrast media and injectors across the health care is doing more with less or maximizing the utility of the existing technology. The companies have started shifting rapidly toward integrating the injector systems with automation technology, such as electronic medical records, for automatic record and analysis of contrast dose data and picture archiving and communication systems. The companies, such as Bayer Healthcare, Bracco, Covidien, and Nemoto Kyorindo have established well upon improved sensors, particularly for CT and MRI, followed by dual flow technology, syringeless pressure injectors, power peripherally inserted central catheters (PICCs), and significant involvement of information technology in dedicated hardware and software directly pull the work list and patient data from RIS, PACS, and HIS.

Biopsy is a sample collection process to identify the presence of disease-causing agents in a particular organ. Variety of biopsy procedures are available in the commercial disease diagnosis market, including conventional and advanced biopsy procedures. The report provides an in-depth analysis of the global biopsy devices market based on product, application, guiding technology, and end user. The report includes popularly used products in the market such as needle-based biopsy devices, biopsy forceps, localization wires, and other products. However, the report excludes the drugs used in the process of biopsy and any other device used during the cancer treatment process. Moreover, it does not include liquid biopsy products in the study.

本分析内容主要分析对象是围绕儿童过敏检测及干预提供相关产品及服务的厂商及用户。通过对产业链的梳理，我们理解市场的发展、寻找行业机会，预判发展趋势。通过对厂商的梳理，我们明确领域内厂商的竞争优势与发展方向，树立行业典型。通过用户画像的描绘，我们理解用户需求，为厂商运营及产品走向提供方向。

The growth of the market studied is driven by the increasing number of surgical procedures requiring anesthesia, technological advancements pertaining to anesthesia delivery devices, and rising usage of inhalable anesthetics in the emerging markets, such as China and India. According to the Centers of Disease Control and Prevention (CDC), more than 51 million inpatient surgeries and 53 million outpatient surgeries were performed in the United States in 2017. The number of surgeries has also been increasing in Asia-Pacific (especially in China and India), mainly because of the high patient population levels.

近两年，大健康产业快速发展，但由于其重资产、回报慢及公益属性等特征，大健康企业也多制约于政策监管、资金储备、技术科技等因素，发展较慢。本篇报告针对大健康企业在发展过程中遇到的资金壁垒进行研究剖析，探索产业金融与大健康企业的融合，以寻求解决方案。

The pest control market is segmented into type, pest type, application, and region. Based on type, the market is classified into chemical, mechanical, biological, and others. Based on pest type, the market is divided into insects, termites, rodents, and others. Based on application, the market is categorized into commercial, residential, agriculture, industrial, and others. Based on region, the market is analyzed across 15 Europe countries, which include Germany, UK, France, Italy, Spain, Netherlands, Switzerland, Poland, Czech Republic, Austria, Belgium, Greece, Slovakia, Portugal, Ireland, and rest of the Europe.

The Europe mobile cardiac telemetry systems market is estimated to grow at a CAGR of 13.0% from 2019 - 2027. The market of mobile cardiac telemetry systems in the Europe region is majorly contributed by the Germany and Germany is the largest market for the mobile cardiac telemetry systems. The growth of the market is defined by the products developments done by the companies in the country like Germany and UK. The top 10 industry players operating in the market of mobile cardiac telemetry systems across the globe includes Medtronic, BioTelemetry Inc., Applied Cardiac Systems, Inc, Medicomp Inc, Preventice Services, LLC, The Scottcare Corporation, Medi-Lynx (Subisidiary Of Medicalgorithmics, S.A), Zoll Medical Corporation, Welch Allyn, and Telerhythmics, LLC.